TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
LNSR

LENSAR Inc

Healthcare · Medical Devices

7.20$ -1.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LNSR
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +19.6% +129.1% -16.0% -16.0% +24.6% -4.7% +7.7%
– +46.3% +239.8% -23.2% -24.8% +37.8% -9.6% +11.4%
– +38.0% +779.7% -22.1% -53.6% +40.5% -21.1% -20.2%
– +38.0% +779.7% -22.1% -53.6% +64.0% -6.7% -19.9%
– +17.7% -36.8% +103.1% +25.1% -30.7% +49.9% -1.6%
– +98.5% +67.1% -51.8% +80.9% +33.6% -27.2% +88.3%
– -16.9% +169.1% -7.9% +27.7% – – –
– +8.7% -9.4% -10.2% +11.5% -9.0% -44.6% -15.1%
– +31.9% -81.7% -2.7% +19.6% +61.7% +112.6% +104.5%
– +2.2% +8.1% +2.9% +31.1% +1.8% +29.0% +170.4%
– +70.0% -55.6% +3.9% +3.7% +5.3% -6.3% +42.6%
– +11.7% +57.3% +8.6% +101.3% -26.1% +49.6% +216.6%
– – – – – – – –
– – – -18.3% -23.5% +12.4% -60.5% -239.5%
– – – – – – – –
– +894.3% +2.8% -14.3% +8.4% +8.0% +5.0% +3.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?